Single-arm phase II to evaluate the safety and efficacy of Campath in combination with high-dose methylprednisolone in CLL patients with deletion of the p53 tumour suppressor gene.

2012 ◽  
Author(s):  
Stacey Gerard
Keyword(s):  
Phase Ii ◽  
Suppressor Gene ◽  
Tumour Suppressor Gene ◽  
Tumour Suppressor ◽  
High Dose ◽  
Safety And Efficacy ◽  
High Dose Methylprednisolone ◽  
P53 Tumour Suppressor Gene

p53 tumour suppressor gene and the tobacco industry

The Lancet ◽  
2005 ◽  
Vol 365 (9464) ◽  
pp. 1026-1027
Author(s):  
Asaf Bitton ◽  
Mark Neuman ◽  
Joaquin Barnoya ◽  
Stanton Glantz
Keyword(s):  
Tobacco Industry ◽  
Suppressor Gene ◽  
Tumour Suppressor Gene ◽  
Tumour Suppressor ◽  
P53 Tumour Suppressor Gene

scholarly journals Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer

1991 ◽  
Vol 64 (6) ◽  
pp. 1076-1082 ◽  
Author(s):  
CM Barton ◽  
SL Staddon ◽  
CM Hughes ◽  
PA Hall ◽  
C O'Sullivan ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Suppressor Gene ◽  
Tumour Suppressor Gene ◽  
Tumour Suppressor ◽  
Human Pancreatic Cancer ◽  
P53 Tumour Suppressor Gene

p53 Tumour Suppressor Gene Mutations in Benign Prostatic Hyperplasia and Prostate Cancer

1998 ◽  
Vol 34 (5) ◽  
pp. 433-440 ◽  
Author(s):  
Horst Schlechte ◽  
Severin V. Lenk ◽  
Thomas Löning ◽  
Dietmar Schnorr ◽  
Birgit D. Rudolph ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Benign Prostatic Hyperplasia ◽  
Gene Mutations ◽  
Suppressor Gene ◽  
Tumour Suppressor Gene ◽  
Prostatic Hyperplasia ◽  
Tumour Suppressor ◽  
P53 Tumour Suppressor Gene
Sign in / Sign up

Export Citation Format

Share Document